Published 19 May 2009, doi:10.1136/bmj.b2026
Cite this as: BMJ 2009;338:b2026

News

Study of device to treat severely injured soldiers in Iraq was fake, claims army

Jeanne Lenzer

1 New York

The first 150 words of the full text of this article appear below.

A top surgeon has been charged by officials at Walter Reed Army Medical Center with falsifying data from a study about the efficacy of a surgical device used to treat soldiers in Iraq with blast injuries to the tibia.

He is also charged with forging the signatures of all four of his coauthors in the study (Journal of Bone and Joint Surgery 2008;90:1068-72).

The 48 year old surgeon, Timothy Kuklo, claimed a 92% success rate in treating open tibia fractures with the Infuse device, a small cage that contains protein used in the manufacture of new bone. The article, "Recombinant human bone morphogenetic protein-2 for grade III open segmental tibial fractures from combat injuries in Iraq," was retracted in March after Walter Reed notified the journal of its findings.

Medtronic, the manufacturer of Infuse, stated in an email to the BMJ that Dr Kuklo is a consultant to the . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

In brief
BMJ 2009 338: b2543. [Extract] [Full Text]

Access jobs at BMJ Careers
Whats new online at Student BMJ